Meetings & Events

Program Overview

May 20, 2020

ENDO Online 2020’s comprehensive program offers attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. Join us for a mixture of live and on-demand content and stay at the forefront of scientific discovery and high-quality patient care.

Daily Event Schedule

(all times are listed in ET)

Monday, June 8

Time	Session
10:00 – 11:00 AM	The Impact of COVID-19 on Endocrinology Developed in collaboration with the European Society of Endocrinology Chairs: John Newell-Price, MD, PhD, FRCP and Andrea Giustina, MD Impact of Diabetes/Obesity on Adverse Outcomes from COVID-19 Manuel Puig-Domingo, MD, PhD Practical Management of Diabetes in Patients with COVID-19 Daniel J. Drucker, MD Clinical Guidance for Patients with Adrenal Insufficiency During COVID-19 Pandemic Wiebke Arlt, MD, DSc, FRCP, FMedSci Panel Discussion with Faculty Drs. Arlt, Drucker, Guistina, Newell-Price, and Puig-Domingo
12:00 – 1:30 PM	Improving Outcomes in Acromegaly: Let Patients Be Your Guide

Time

Session

10:00 – 11:00 AM

The Impact of COVID-19 on Endocrinology
Developed in collaboration with the European Society of Endocrinology

Chairs: John Newell-Price, MD, PhD, FRCP and Andrea Giustina, MD

Impact of Diabetes/Obesity on Adverse Outcomes from COVID-19
Manuel Puig-Domingo, MD, PhD

Practical Management of Diabetes in Patients with COVID-19
Daniel J. Drucker, MD

Clinical Guidance for Patients with Adrenal Insufficiency During COVID-19 Pandemic
Wiebke Arlt, MD, DSc, FRCP, FMedSci

12:00 – 1:30 PM

Improving Outcomes in Acromegaly: Let Patients Be Your Guide

Tuesday, June 9: Basic Science Day

Time	Session
10:00 – 11:00 AM	Basic Mechanisms in Reproduction: From Beginning to End Chair: Genevieve Scott Neal-Perry, PhD, MD Regulation of Mouse Uterine Contractility by Regulator of G-Protein Signalling 2 Daniela Urrego, BHSc Kisspeptin as a Biomarker for Pregnancy Complications Maria Phylactou, MBBS Ovarian Follicle Survival Is Determined by Follicle-Stimulating Hormone Receptor (FSHR) and Estrogen Receptor (GPER) Heteromers Livio Casarini, PhD The Expression of the Homeodomain Transcription Factor SIX3 within Kisspeptin Neurons Is Necessary for Reproduction in Mice Shanna Newton Lavalle, BS
11:00 AM – 12:00 PM	The Many Faces of Diabetes, Obesity, and Metabolism Chair: Kevin Y Lee, PhD Circadian Regulation of Chromatin State Mediates Pancreatic Islet Incretin Response Benjamin John Weidemann, BS Hepatocyte Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Offsets the Anti-Steatogenic Effects of Thiazolidinediones in Obese Male Mice Jose T Muratalla, Biochemistry Undergrad The Transcriptional Coactivation Function of EHMT2 Restricts Chronic Glucocorticoid Exposure Induced Insulin Resistance Rebecca Arwyn Lee, MS Epinephrine Is Essential for Normal Renal Glucose Reabsorption via the Glucose Transporter GLUT2 Arwa Mahmoud Elsheikh, MBBS
12:00 – 1:00 PM	Key Note: If We Knew Then What We Know Now, Would We Have Approached The Development of Endocrine Therapies Differently Donald McDonnell, PhD
1:00 – 2:00 PM	The Many Faces of Nuclear Receptor Biology Chair: Patricia Virginia Elizalde, PhD Kruppel-Like Factors 9 and 13 Cooperate to Maintain Mammalian Neuronal Differentiation Jose Avila-Mendoza, PhD Expression of SLC35F1 in the Plasma Membrane of Cells of Aldosterone Producing Cell Clusters (APCCs) and Its Possible Role in Aldosterone Synthesis Emily Goodchild, BMBS, BSc Nuclear Receptor CAR Protects Female Mice from the Development of Diet-Induced Nonalcoholic Fatty Liver Disease Fabiana Oliviero, Master's Degree When the Glucocorticoid Receptor Meets the Mineralocorticoid Receptor in the Nucleus of Human Cells Maria G. Petrillo, PhD
2:00 – 3:00 PM	From the Brain to the Belly – Insights into Pituitary and Adrenal Physiology Chair: Lori Therese Raetzman, PhD OTX2 Mutations in Congenital Hypopituitarism Patients Louise Cheryl Gregory, PhD Single-Cell Sequencing Identifies Novel Regulators of Thyrotrope Populations and POU1F1-Independent Thyroid-Stimulating Hormone Expression Leonard Cheung, PhD Glucocorticoid Production in the Nervous and Immune Systems: Evidence for a Local HPA Axis Homolog Melody Salehzadeh, BSc Sepsis-Induced Critical Illness in Mice Alters Key Regulators of ACTH Production and Secretion Within the Anterior Pituitary Gland Arno Téblick, MD

Wednesday, June 10

Time	Session
10:00 AM – 12:00 PM	Exhibit Hall Hours
12:00 – 1:30 PM	Breaking Bad: Reducing Glucose Variability and Increasing Time in Range in Patients with Diabetes

Thursday, June 11

Time	Session
10:00 AM – 12:00 PM	Exhibit Hall Hours
12:00 – 1:30 PM	Breaking the Cycle: Approaches to Long-Term Weight Loss and Obesity Care

Friday, June 12

Time	Session
10:00 AM – 12:00 PM	Exhibit Hall Hours
1:00 PM – 1:45 PM	What’s New with ABIM’s Maintenance of Certification? Susan J. Mandel, MD, MPH

Monday, June 15

Time	Session
10:00 AM – 12:00 PM	Exhibit Hall Hours
12:00 – 1:30 PM	Blazing Ahead with Advances in the Management of Adult Growth Hormone Disorder

Tuesday, June 16

Time	Session
10:00 AM – 12:00 PM	Exhibit Hall Hours
12:00 – 1:00 PM	What Else You Should Know About Resiliency, Communications, Collaborations, and Teaching Strategies: A Live Question and Answer Session with Faculty

Wednesday, June 17

Time	Session
10:00 AM – 12:00 PM	Exhibit Hall Hours
12:00 – 1:30 PM	Severe Hypoglycemia: The Frequently Forgotten Threat

Thursday, June 18

Time	Session
12:00 – 1:00 PM	Type One Diabetes Fellows Conference Questions and Answers with the Faculty
1:00 – 1:30 PM	Device Demonstration by Abbott Diabetes Care, Inc.
1:30 – 2:00 PM	Device Demonstration by Insulet Corporation

Friday, June 19

Time	Session
12:00 – 12:30 PM	Device Demonstration by Medtronic Diabetes
12:30 – 1:00 PM	Device Demonstration by Dexcom, Inc.
1:00 – 1:30 PM	Device Demonstration by Tandem Diabetes Care, Inc.

On-Demand Sessions will be available for you to view at your convenience starting on Monday, June 8 at 11:00 AM following ENDOOnline’s Opening Session, The Impact of COVID-19 on Endocrinology.

Professional Development Sessions

Session
Breaking Barriers to Care Increasing Patient Participation in Research: Strategies for Success James R. Gavin, PhD, MD Reconsidering Race in the Estimation of Kidney Function Nwamaka D. Eneanya, MD, MPH
Effective Teaching Strategies Nuha A. El Sayed, MD, MM Sc Mark S. Roberson, PhD
Resiliency and Managing Burnout Stanley Andrisse, PhD Deborah T. Rana, MSc, MD, FAAP Stuart Slavin, MD, MEd
Transcending Boundaries: How to Effectively Build Global Networks and Partnerships Diana Cruz Topete, PhD Mirjam Christ-Crain, MD, PhD

Meet the Professor Clinical Sessions

Session
Controversies in Bariatric Surgery Jenny Tong MD, MPH Marzieh Salehi, MD
Healthcare of the Transwoman Across the Lifespan Vin Tangpricha MD, PhD
Moderate to Severe Active Thyroid Eye Disease Chrysoula Dosiou, MD Andrea Kossler, MD
Pharmacotherapy in Obesity Marc-Andre Cornier, MD David Saxon, MD, MSc
Type 1 Diabetes Mellitus: From Preconception to Postpartum Elizabeth Buschur, MD

Educational Sessions

Session
2020 Endocrine Fellows Series: Type 1 Diabetes Care and Management A Fresh Look at Insulin Therapy Challenging Cases in the Diagnosis of T1D Practical Considerations and Approaches to Data Management Irl B. Hirsch, MD Developmental Considerations For Youth with T1D and Their Families Jill Weissberg-Benchell, PhD, CDE Exercise Management: Considerations and Strategies for T1D Michael Riddell, PhD Hypoglycemia in T1D: Risks and Practical Prevention Strategies Elizabeth Rachel Seaquist, MD Identifying and Confronting Challenging Transitions Linda M. Siminerio, RN, PhD, CDE Implementing Realistic Nutrition Strategies Alison Evert, MS, RD, CDE Insights into Insulin Pump Therapy The Endocrinologist’s Role in Screening/Managing Microvascular Disease Janet B. McGill, MD Interpreting CGM with Your Patients Davida F. Kruger, Masters Managing the Sick Patient at Home Optimizing Multiple Daily Injection Therapy Jenise Colleen Wong, MD, PhD Time in Range: The Power of Partnership Kelly Close, MBA
Telemedicine in the Age of COVID-19 Developed in collaboration with the European Society of Endocrinology Chairs: Gary D. Hammer, MD and Martin Reincke, MD Perspectives on Rare Endocrine Conditions Alberto M. Pereira Arias, MD, PhD Lessons Learned from Virtual Tumor Boards Sophie Leboulleux, MD New Use of Home Lab Measurements for e-consults Ravinder J. Singh, PhD
Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline Moderator: Marie E. McDonnell, MD Task Force Chair: James L. Rosenzweig, MD Panelists: Lars F. Berglund, MD, PhD Marie-France Hivert, MD Rita R. Kalyani, MD
The Year in Pituitary: Clinical and Research Breakthroughs Mirjam Christ-Crain, MD, PhD

Clinical Trial Abstract Presentations

Session
Adrenal Medicine – Clinical Applications and New Therapies A Phase 3 Study of a Modified-Release Hydrocortisone in the Treatment of Congenital Adrenal Hyperplasia Deborah P. Merke, MS, MD The Effects of Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, on Adrenal Androgens and Precursors in Patients with Classic Congenital Adrenal Hyperplasia: Results from A Multiple-Dose Phase 2 Study Richard Joseph Auchus, MD, PhD
Challenges in Reproductive Endocrinology: Late Breaking Insights Using Kisspeptin to Predict Pubertal Outcomes for Youth With Pubertal Delay Yee-Ming Chan, MD, PhD
Clinical Challenges in Diabetes and Metabolism Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11) Juan Pablo Frias, MD Leptin Decreases De Novo Lipogenesis in Lipodystrophic Patients Ahmed M. Gharib, MD Annah Petek Baykal, BS Racial Differences in Technology Use Among Type 1 Diabetes in a Safety-Net Hospital Kathryn Fantasia, MD
Mechanisms and Treatment of Obesity in Humans Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial Aaron S. Kelly, PhD
New Frontiers in Bone and Mineral Metabolism Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome Thomas O. Carpenter, MD Long-Term Safety in Adults with X-Linked Hypophosphatemia (XLH) Treated with Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial Farzana Perwad, MD Romosozumab Treatment Lowers the Incidence of New Vertebral Fractures Across All Fracture Severity Grades Among Postmenopausal Women with Osteoporosis Robert A. Feldman, MD Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss Anne Sophie Sølling, MD
Thyroid Autoimmunity and Benign Thyroid Disease An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC) Lori J. Wirth, MD
Understanding Pediatric Growth Disorders Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency Aristides K. Maniatis, MD Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial Cheri L. Deal, MD, PhD

Product Theater Presentations and Exhibits offer ENDO 2020 Online learners additional educational opportunities. A number of companies will provide a 30-minute focused presentation on the latest products available on the market that clinicians and advanced practice professionals that can impact your practice. Additionally, through the virtual exhibit hall that you can continue your educational journey to learn more about products that can make a difference to your patients.

Product Theaters
NP Thyroid® (Thyroid Tablets, USP): Understanding the Options for Management of Hypothyroidism For the majority of patients seeking treatment for hypothyroidism and Hashimoto’s thyroiditis, levothyroxine (LT4) monotherapy is the recommended first line treatment. However, many patients remain symptomatic despite achieving normal lab values and thyroid function tests. There is a growing body of clinical evidence that suggests certain subsets of patients with hypothyroidism, such as those with genetic polymorphisms of the D2 deiodinase gene, may benefit from combination therapy with both T4 and T3. This product theater will provide a synopsis of the management of hypothyroidism with combination therapy as well as an overview of NP Thyroid, which is a natural desiccated porcine thyroid extract containing both T4 and T3 indicated for thyroid hormone replacement in hypothyroidism and Hashimoto’s thyroiditis. Presenter: Gary M. Pepper, MD Palm Beach Diabetes & Endocrine Specialists Palm Beach, FL Sponsored by Acella Pharmaceuticals
The Next Generation of the Guardian™ Connect Continuous Glucose Monitoring System: Accuracy When it Matters Most with Real World Outcomes Introduction to the new Guardian™ Connect CGM app, featuring even more customizable prediction, easier onboarding, and new CareLink™ reports for your practice. Please join us to learn more about the system and the different measures of accuracy, with real world outcomes and case studies demonstrating the integration of CareLink™ reports to help you manage your patients on multiple daily injections. Presenter: Bruce Bode, MD Sponsored by Medtronic
A Paradigm Shift for the Management of Thyroid Eye Disease (TED) Come learn about the importance of early identification and a new treatment approach for Thyroid Eye Disease (TED) management. This presentation is intended for US-based healthcare professionals. Presenters: Raymond S. Douglas, MD, PhD Professor of Ophthalmology Director, Orbital and Thyroid Eye Disease Center Cedars-Sinai Medical Center, Los Angeles, CA Terry J. Smith, MD Frederick G.L. Huetwell Professor of Ophthalmology and Visual Sciences Professor, Department of Internal Medicine Kellogg Eye Center University of Michigan Medical School, Ann Arbor, MI Sponsored by Horizon Therapeutics
Enabling Telemedicine and Remote Monitoring with the FreeStyle Libre 14 day System Join us to learn about the #1 CGM worldwide† used by more than 2 million people, the FreeStyle Libre 14 day system. Daniel Einhorn, M.D., FACP, FACE will share how he utilizes the FreeStyle Libre 14 day system to enable diabetes management and monitoring of patients remotely. He will also share real-world telemedicine patient cases. Presenter: Daniel Einhorn, MD, FACP, FACE Medical Director, Scripps Whittier Diabetes Institute Clinical Professor of Medicine, University of California, San Diego President, Diabetes and Endocrine Associates Disclaimers †Data based on the number of users worldwide for FreeStyle Libre personal CGM compared to the number of users for other leading personal CGM brands. Data based on the number of users worldwide for FreeStyle Libre products. In the United States product is branded FreeStyle Libre 14 day System. This program is sponsored by Abbott, the speaker or speakers are presenting on behalf of Abbott and the content of the program is in compliance with applicable regulatory requirements.
Clinical Management of Adrenocortical Carcinoma (ACC) Adrenocortical Carcinoma (ACC) is a rare endocrine tumor with a poor prognosis that requires a multi-disciplinary approach between endocrinologists, oncologists and surgeons. The presentation will focus on the diagnosis, prognosis and current treatment guidelines for ACC patients. Presenter: Mouhammed Amir Habra, MD, F.A.C.P., F.A.C.E. Associate Professor, Deptartment of Endocrine Neoplasia and Hormonal Disorders MD Anderson Cancer Center, Houston, TX Sponsored by HRA Pharma Rare Diseases
Precision Medicine in Skeletal Dysplasias: Genetics, Pathophysiology, & Investigational Approaches to Therapy More than 400 skeletal dysplasias have a genetic basis of disease identified. Currently, these patients may experience lifelong, progressive, multisystemic comorbidities. This on-demand presentation, moderated by Dr. Ron Rosenfeld, brings together 4 experts who will discuss the genetic basis of skeletal dysplasias, their pathophysiology, and the development of investigational therapies for achondroplasia. Chair and Presenter: Ron Rosenfeld, MD Pediatric Endocrinologist Professor and Chair (emeritus) of Pediatrics Oregon Health and Science University Presenters: Julie Hoover-Fong, MD, PhD Clinical Geneticist Greenberg Center for Skeletal Dysplasias McKusick-Nathans Department of Genetic Medicine Johns Hopkins University, Baltimore, MD Nadia Merchant, MD Pediatric Endocrinologist & Clinical Geneticist Children’s National Hospital, Washington, DC Bradley S. Miller, MD, PhD Professor Division of Endocrinology Department of Pediatrics University of Minnesota Masonic Children’s Hospital, Minneapolis, MN Sponsored by BioMarin Pharmaceuticals
Finally, an Oral Testosterone Replacement Therapy for Men with Hypogonadism Join us for an overview of an FDA-approved and available oral testosterone replacement therapy. During this program, an expert will discuss the history and challenges of TRTs, and the pathway to approval for this oral option, as well as its safety and efficacy profiles. Presenter: Paresh Dandona MD, PhD State University of New York at Buffalo, Buffalo, New York Sponsored by Clarus Therapeutics
Product Theater presentations are not part of ENDO Online 2020 official educational programming as planned by the Endocrine Society Program Committee. These events are neither sponsored nor endorsed by the Endocrine Society. These events does not qualify for continuing medical education (CME) credit.

Last Updated: May 20, 2020